vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $360.3M, roughly 1.8× Clearwater Paper Corp). Natera, Inc. runs the higher net margin — 7.1% vs -3.6%, a 10.7% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -4.7%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 2.3%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

CLW vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.8× larger
NTRA
$665.5M
$360.3M
CLW
Growing faster (revenue YoY)
NTRA
NTRA
+44.5% gap
NTRA
39.8%
-4.7%
CLW
Higher net margin
NTRA
NTRA
10.7% more per $
NTRA
7.1%
-3.6%
CLW
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
2.3%
CLW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLW
CLW
NTRA
NTRA
Revenue
$360.3M
$665.5M
Net Profit
$-12.8M
$47.3M
Gross Margin
-0.2%
Operating Margin
-3.4%
Net Margin
-3.6%
7.1%
Revenue YoY
-4.7%
39.8%
Net Profit YoY
-103.2%
187.9%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
NTRA
NTRA
Q1 26
$360.3M
Q4 25
$386.4M
$665.5M
Q3 25
$399.0M
$592.2M
Q2 25
$391.8M
$546.6M
Q1 25
$378.2M
$501.8M
Q4 24
$387.1M
$476.1M
Q3 24
$393.3M
$439.8M
Q2 24
$344.4M
$413.4M
Net Profit
CLW
CLW
NTRA
NTRA
Q1 26
$-12.8M
Q4 25
$38.3M
$47.3M
Q3 25
$-53.3M
$-87.5M
Q2 25
$2.7M
$-100.9M
Q1 25
$-6.3M
$-66.9M
Q4 24
$199.1M
$-53.8M
Q3 24
$5.8M
$-31.6M
Q2 24
$-25.8M
$-37.5M
Gross Margin
CLW
CLW
NTRA
NTRA
Q1 26
-0.2%
Q4 25
4.5%
Q3 25
4.7%
Q2 25
11.0%
Q1 25
9.7%
Q4 24
3.8%
Q3 24
7.7%
Q2 24
-0.6%
Operating Margin
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
1.9%
-3.4%
Q3 25
-13.9%
-16.5%
Q2 25
2.5%
-20.2%
Q1 25
-1.1%
-15.8%
Q4 24
-4.0%
-13.6%
Q3 24
-0.3%
-8.9%
Q2 24
-13.6%
-10.6%
Net Margin
CLW
CLW
NTRA
NTRA
Q1 26
-3.6%
Q4 25
9.9%
7.1%
Q3 25
-13.4%
-14.8%
Q2 25
0.7%
-18.5%
Q1 25
-1.7%
-13.3%
Q4 24
51.4%
-11.3%
Q3 24
1.5%
-7.2%
Q2 24
-7.5%
-9.1%
EPS (diluted)
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
$2.36
$0.36
Q3 25
$-3.30
$-0.64
Q2 25
$0.17
$-0.74
Q1 25
$-0.38
$-0.50
Q4 24
$11.87
$-0.41
Q3 24
$0.35
$-0.26
Q2 24
$-1.55
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$36.5M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$813.8M
$1.7B
Total Assets
$1.6B
$2.4B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
NTRA
NTRA
Q1 26
$36.5M
Q4 25
$30.7M
Q3 25
$34.4M
$1.0M
Q2 25
$46.7M
$16.0M
Q1 25
$44.0M
$17.8M
Q4 24
$79.6M
$22.7M
Q3 24
$35.5M
$29.5M
Q2 24
$39.6M
$90.3M
Total Debt
CLW
CLW
NTRA
NTRA
Q1 26
$361.1M
Q4 25
$346.8M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
Q3 24
$1.2B
Q2 24
$1.1B
Stockholders' Equity
CLW
CLW
NTRA
NTRA
Q1 26
$813.8M
Q4 25
$825.3M
$1.7B
Q3 25
$783.0M
$1.3B
Q2 25
$836.8M
$1.2B
Q1 25
$836.6M
$1.2B
Q4 24
$854.6M
$1.2B
Q3 24
$664.6M
$878.5M
Q2 24
$658.6M
$836.5M
Total Assets
CLW
CLW
NTRA
NTRA
Q1 26
$1.6B
Q4 25
$1.6B
$2.4B
Q3 25
$1.6B
$1.8B
Q2 25
$1.6B
$1.8B
Q1 25
$1.6B
$1.7B
Q4 24
$1.7B
$1.7B
Q3 24
$2.5B
$1.6B
Q2 24
$2.5B
$1.5B
Debt / Equity
CLW
CLW
NTRA
NTRA
Q1 26
0.44×
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
$5.0M
$73.9M
Q3 25
$34.0M
$59.4M
Q2 25
$-28.2M
$37.6M
Q1 25
$1.5M
$44.5M
Q4 24
$-35.1M
$52.9M
Q3 24
$16.2M
$51.8M
Q2 24
$21.1M
$4.0M
Free Cash Flow
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
$-9.9M
$37.8M
Q3 25
$15.7M
$37.0M
Q2 25
$-51.1M
$11.7M
Q1 25
$-31.2M
$22.6M
Q4 24
$-68.1M
$34.8M
Q3 24
$-30.8M
$35.5M
Q2 24
$3.0M
$-7.7M
FCF Margin
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
-2.6%
5.7%
Q3 25
3.9%
6.2%
Q2 25
-13.0%
2.1%
Q1 25
-8.2%
4.5%
Q4 24
-17.6%
7.3%
Q3 24
-7.8%
8.1%
Q2 24
0.9%
-1.9%
Capex Intensity
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
3.9%
5.4%
Q3 25
4.6%
3.8%
Q2 25
5.8%
4.7%
Q1 25
8.6%
4.3%
Q4 24
8.5%
3.8%
Q3 24
12.0%
3.7%
Q2 24
5.3%
2.8%
Cash Conversion
CLW
CLW
NTRA
NTRA
Q1 26
Q4 25
0.13×
1.56×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons